Andrew Whiteley, Alex Titomirov & David Lowe | GenomeWeb

InforMax, the Bethesda, Md., maker of the GenoMax enterprise bioinformatics system, has appointed Andrew Whiteley as its new chairman, chief executive officer and president. Whiteley, who will assume his duties on April 1, comes to InforMax from Amersham Biosciences, where he most recently served as vice president of bioinformatics. Whiteley also held positions as vice president of Amersham’s sequencing business, and site director of Amersham International PLC’s Cleveland facility.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.